Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person triple-receptor negative breast cancer

Class:IdDisease:9701258
_displayNametriple-receptor negative breast cancer
_timestamp2020-09-25 14:49:22
created[InstanceEdit:9701267] Orlic-Milacic, Marija, 2020-09-25
definitionA breast cancer that is characterized by the absence of estrogen, progresterone and Her2 receptors.
identifier0060081
nametriple-receptor negative breast cancer
referenceDatabase[ReferenceDatabase:1247631] DOID
(disease)[EntityWithAccessionedSequence:9702429] BRCA1 E1210* [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9702740] BRCA1 R388* [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9702754] BRCA1 S451* [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9703472] BRCA1 E1115* [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9703475] BRCA1 C1225Sfs*10 [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9703774] BRCA1 N555Ifs*17 [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9703778] BRCA1 P724Lfs*12 [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:9709587] BRCA2 G1529R [nucleoplasm] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by triple-receptor negative breast cancer (9701258)